Literature DB >> 34382142

Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies.

Shrenik Mehta1, Heather Flores1, Benjamin Walters2, Alavattam Sreedhara3.   

Abstract

PURPOSE: To evaluate the physical and chemical degradation of monoclonal antibodies in the presence of Zn2+.
METHODS: A full length IgG1 monoclonal antibody (mAb1) was formulated with various amounts of Zn2+. The resulting mixture was incubated for several weeks at room temperature and analyzed using a variety of biochemical techniques to look for various physical (e.g. aggregation) and chemical (e.g. fragmentation) degradation pathways.
RESULTS: mAb1 of the IgG1 subclass undergoes aggregation in the presence of Zn2+ in a concentration dependent manner. Up to hexamers were characterized using SEC-MALS. No fragmentation was noticed in the presence of Zn2+ as opposed to that found in our previous report when IgG1 mAbs were incubated in the presence of Cu2+ ions. Site directed mutagenesis indicated the involvement of Fc histidine (His 310) in Zn2+ mediated aggregation.
CONCLUSIONS: A novel metal ion mediated isodesmic aggregation mechanism was found in IgG1 class of monoclonal antibodies. Histidine residues in the Fc region were determined to be the binding site and implicated in Zn2+ mediated aggregation.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  IgG1 monoclonal antibodies; Zn2+ mediated aggregation; high molecular weight species; isodesmic polymerization

Mesh:

Substances:

Year:  2021        PMID: 34382142     DOI: 10.1007/s11095-021-03089-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  Identification of multiple sources of charge heterogeneity in a recombinant antibody.

Authors:  R J Harris; B Kabakoff; F D Macchi; F J Shen; M Kwong; J D Andya; S J Shire; N Bjork; K Totpal; A B Chen
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-10

2.  Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.

Authors:  Shuxia Zhou; Brad Evans; Christian Schöneich; Satish K Singh
Journal:  AAPS PharmSciTech       Date:  2012-01-13       Impact factor: 3.246

Review 3.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

4.  High zinc ion supplementation of more than 30 μM can increase monoclonal antibody production in recombinant Chinese hamster ovary DG44 cell culture.

Authors:  Bong Gyun Kim; Hong Woo Park
Journal:  Appl Microbiol Biotechnol       Date:  2015-10-29       Impact factor: 4.813

5.  Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed.

Authors:  Wendy B Chaderjian; Edward T Chin; Reed J Harris; Tina M Etcheverry
Journal:  Biotechnol Prog       Date:  2005 Mar-Apr

Review 6.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

7.  A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.

Authors:  Sheryl Martin-Moe; Fredric J Lim; Rita L Wong; Alavattam Sreedhara; Jagannathan Sundaram; Samir U Sane
Journal:  J Pharm Sci       Date:  2011-03-18       Impact factor: 3.534

8.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

9.  Characterization of the isomerization products of aspartate residues at two different sites in a monoclonal antibody.

Authors:  Alavattam Sreedhara; Armando Cordoba; Qing Zhu; Jeanne Kwong; Jun Liu
Journal:  Pharm Res       Date:  2011-08-02       Impact factor: 4.200

10.  Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.

Authors:  J Cacia; R Keck; L G Presta; J Frenz
Journal:  Biochemistry       Date:  1996-02-13       Impact factor: 3.162

View more
  1 in total

1.  Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.

Authors:  Zephania Kwong Glover; Aaron Wecksler; Baikuntha Aryal; Shrenik Mehta; Melissa Pegues; Wayman Chan; Mari Lehtimaki; Allen Luo; Alavattam Sreedhara; V Ashutosh Rao
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.